Assessment of Depression among IBD patients in Gastroenterology and Hepatology Specialized Hospital, Medical City, Iraq using the PHQ-9
DOI:
https://doi.org/10.32007/jfacmedbagdad.2071Keywords:
IBD, PHQ-9, Depression, Crohn's, Ulcerative Colitis, AnxietyAbstract
Background: The management of patients with inflammatory bowel disease (IBD) must take mental health into account because it might be difficult to find the best therapies and mental health resources. Anxiety and depression are the two psychological illnesses that IBD patients experience most frequently. The growing incidence of these mental illnesses encourages mental screening of every IBD patient at the initial session. There are easy-to-use, scientifically effective screening techniques for mental health issues. As important as or even more so than a therapy modality may be psychological techniques.
Objective: To assess the level of depression among IBD patients in the Gastroenterology and Hepatology Specialized Hospital, Medical City, Ministry of Health and Environment.
Patients and methods: The patients were provided with the three-page Patient Health Questionnaire (PHQ) as a self-administrated tool to learn more about their health. When completed, the doctor scans the completed questionnaire, verifies the "yes" responses, and then applies the diagnostic algorithms, which are briefly listed at the bottom of each page. This study was conducted on 98 patients with IBD attending the Gastroenterology and Hepatology Specialized Hospital, Medical City, Baghdad during the period from January – June 2022.
Results: Of the total number of cases included in the study 47 (47.9%) were females and 51 (52.1%) were males. The highest frequency was for young adults, 48 cases (49%), and the lowest was for children, 9 (9.2%). There were 43 cases with Ulcerative Colitis and 55 with Crohn's disease. According to the PHQ-9 score, 26 cases (26.5%) had mild scores and 9 (9.2%) cases had severe scores. The highest frequency of PHQ-9 scores was in the moderately severe range with 44 (44.9%).
Conclusion: Mild and moderate levels of depression were the most prevalent among IBD patients across all age and sex groups, which should encourage physicians to address the mental health status of their patients and to include mental health care in the routine checkup of their patients.
Received: Feb,, 2023
Accepted: Oct, 2023
Published: Jan.2024
Downloads
References
. Mowat C, Cole A, Windsor A, Ahmad T, Arnott I, Driscoll R, et al. IBD Section of the British Society of Gastroenterology. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2011 May;60(5):571-607. doi: 10.1136/gut.2010.224154. PMID: 21464096.
https://doi.org/10.1136/gut.2010.224154.
Magro F, Gionchetti P, Eliakim R, Ardizzone S, Armuzzi A, Barreiro-de Acosta M, et al. European Crohn's and Colitis Organisation [ECCO]. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. J Crohns Colitis. 2017 Jun 1; 11(6):649-670. Erratum in: J Crohns Colitis. 2022 Aug 16; PMID: 28158501. https://doi.org/10.1093/ecco-jcc/jjx008.
Andrews JM, Mountifield RE, van Langenberg DR, Bampton PA, Holtmann GJ. Un-promoted issues in inflammatory bowel disease: opportunities to optimize care. Intern Med J 2010;40(3):173-82.
https://doi.org/10.1111/j.1445-5994.2009.02110.x.
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13.PMID: 11556941; PMCID: PMC1495268. https://doi.org/10.1046/j.15251497.2001.016009606.x. 5. Gomollón F, Dignass A, Annese V, Tilg H, Van Assche G, Lindsay JO, et al. ECCO. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management. J Crohns Colitis. 2017 Jan;11(1):3-25. Epub 2016 Sep 22. PMID: 27660341. https://doi.org/10.1093/ecco-jcc/jjw168.
Gearry RB, Richardson AK, Frampton CM, Dodgshun AJ, Barclay ML. Population-based cases control study of inflammatory bowel disease risk factors. J Gastroenterol Hepatol 2010;25(2):325-33.
https://doi.org/10.1111/j.1440-1746.2009.06140.x.
Ng SC, Tang W, Ching JY, Wong M, Chow CM, Hui AJ, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-Pacific Crohn's and colitis epidemiology study. Gastroenterology 2013;145:158-65. https://doi.org/10.1053/j.gastro.2013.04.007.
Ng SC. Emerging leadership lecture: Inflammatory bowel disease in Asia: emergence of a "Western" disease. J Gastroenterol Hepatol 2015;30: 440-5. https://doi.org/10.1111/jgh.12859.
Ghosh S, Mitchell R. Impact of inflammatory bowel disease on quality of life: Results of the European Federation of Crohn's and Ulcerative Colitis Associations (EFCCA) patient survey. J Crohns Colitis 2007;1(1):10-20. https://doi.org/10.1016/j.crohns.2007.06.005.
Alarhayem A, Achebe E, Logue AJ. Psychosocial Support of the Inflammatory Bowel Disease Patient. Surg Clin North Am. 2015 Dec;95(6):1281-93, vii-viii. https://doi.org/10.1016/j.suc.2015.08.005.
Spitzer RL, Kroenke K, Williams JBW. Patient Health Questionnaire Study Group. Validity and utility of a self-report version of PRIME-MD: the PHQ Primary Care Study. JAMA. 1999;282: 1737-4
https://doi.org/10.1001/jama.282.18.1737.
AlHadi AN, AlAteeq DA, Al-Sharif E, Bawazeer HM, Alanazi H, AlShomrani AT, et al. An arabic translation, reliability, and validation of Patient Health Questionnaire in a Saudi sample. Ann Gen Psychiatry. 2017 Sep 6;16:32. PMID: 28878812; PMCID: PMC5585978. https://doi.org/10.1186/s12991-017-0155-1.
Prajapati, Jignesh & Patel, Ankit & Raninga, Punit. (2014). Facial Age Group Classification. IOSR Journal of Electronics and Communication Engineering. 9. 33-39. 10.9790/2834-09123339. https://doi.org/10.9790/2834-09123339.
Alam R, Abdolmaleky HM, Zhou JR. Microbiome, inflammation, epigenetic alterations, and mental diseases. Am. J. Med. Genet. Part B Neuropsychiatr. Genet. 2017, 174, 651-660. [Google Scholar] [CrossRef]
https://doi.org/10.1002/ajmg.b.32567.
Hu S, Chen Y, Chen Y, Wang C. Depression and Anxiety Disorders in Patients with Inflammatory Bowel Disease. Front Psychiatry. 2021 PMID: 34690829;PMCID:PMC8531580.
https://doi.org/10.3389/fpsyt.2021.714057.
Fracas E, Costantino A, Vecchi M, Buoli M. Depressive and Anxiety Disorders in Patients with Inflammatory Bowel Diseases: Are There Any Gender Differences? Int. J. Environ. Res. Public Health 2023, 20, 6255. https://doi.org/10.3390/ijerph20136255https://doi.org/10.3390/ijerph20136255.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Hani Gh. Jawad, Hadeer Kh. Hasan , Zainab A. Abdulameer &Qusay Y. Hamad
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Creative Commons Attribution 4.0 International license..
